Dr. Alpdogan has contributed to studies on hematopoietic stem cell transplantation (HSCT) for various lymphomas, including primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma . He has also co-authored research on the outcomes of older patients undergoing haploidentical and matched related peripheral blood HSCT, highlighting the feasibility and outcomes of this approach in an older patient population. His clinical focus on the treatment of B-cell and T-cell lymphomas, including Hodgkin lymphoma, employing therapies such as chemotherapy, immunotherapy, and stem cell transplantation. He has been involved in studies evaluating the efficacy of novel treatments for these conditions.
S. Onder Alpdogan, MD
Associate Professor
Multiple Myeloma
Blood & Marrow Transplant
Contact Information
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Associate Professor
Multiple Myeloma
Blood & Marrow Transplant
RESEARCH & CLINICAL INTEREST
Education
Medical School
Hacettepe University, Ankara, Turkey - 1983
Residency
Marmara University Hospital
Fellowship
Memorial Sloan-Kettering Cancer Center, NY
Yale-New Haven Hospital , New Haven, CT
Most Recent Peer-Reviewed Publications
- Coexistence of large cell transformed mycosis fungoides and diffuse large B-cell lymphoma in one patient
- The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual
- Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma
- A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
- Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study